Gut microbiota and metabolic alterations in participants with flatulence identify Faecalibacterium prausnitzii as a key microbial target for clinical intervention.
Gut MicrobesSep 3, 2026 (epub)
Clinical ResearchGastroenterology
Ruimin Chen, Chuan Zhang, Shikai Yan et al.
✦ AI-curated · Sources linked
In 30 seconds
This randomized controlled trial investigated the gut microbiota and metabolic changes in participants with flatulence, identifying Faecalibacterium prausnitzii as a crucial microbial target. The study found that supplementation with Bifidobacterium longum CCFM1319 significantly increased F. prausnitzii abundance and improved flatulence symptoms, suggesting a potential intervention strategy for managing flatulence.
Key findings
- Participants with flatulence showed significant shifts in gut microbial functions compared to healthy controls.
- Faecalibacterium prausnitzii was negatively associated with high gas production.
- Supplementation with Bifidobacterium longum CCFM1319 improved flatulence-related symptoms.
Why it matters
Understanding the gut microbiota's role in flatulence can inform targeted interventions, potentially leading to more effective management strategies for patients experiencing this common gastrointestinal issue.